Search

everythinglearnresearchcommunity

for

Search:↓

Red deer hair cells offer a new way to study how hormones affect hair growth.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Androgens significantly regulate hair keratin K37 expression.

Future acne treatments should aggressively target inflammation to prevent scarring.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Prostaglandins don't genetically contribute to hair loss.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

New treatments for hair loss are being developed using molecular biology.

Testosterone is made by Leydig cells, is active when not bound to proteins, and works by binding to receptors in muscles and other tissues.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Androgens affect behavior, hair, bones, muscles, and the heart, and can be used to treat certain conditions.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.